Skip to content
Get alerts
GovInfoNow
Stop using now Drug recall · FDA · Published March 12, 2017

EpiPen 2-Pak Auto-Injectors: Defective Delivery May Fail to Administer Epinephrine

Meridian Medical Technologies recalls EpiPen 2-Pak auto-injectors with defective delivery systems that may fail to activate during emergencies, risking inadequate medication for anaphylaxis. Affected units include specific lots manufactured for Mylan Specialty L.P. in Morgantown, WV.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0690-2017DrugMeridian Medical Technologies ›
Take action

Contact the company

Recalling firmMeridian Medical Technologies a Pfizer Company2555 Hermelin Dr · Brentwood, MO 63144-2504
✎ GovInfoNow plain-language explainer

Meridian Medical Technologies recalls EpiPen 2-Pak auto-injectors that may fail to activate during emergencies, potentially leaving patients without critical epinephrine treatment. This defect could be life-threatening for individuals with severe allergies who need immediate response. Read more at govinfonow.com/recall/41815-epipen-2-pak-auto-injectors-defective-delivery-may-fail-to.

Source Summary by GovInfoNow · govinfonow.com/recall/41815-epipen-2-pak-auto-injectors-defective-delivery-may-fail-to · Updated October 8, 2026 · FDA enforcement record: FDA #D-0690-2017

Cite this page

“EpiPen 2-Pak Auto-Injectors: Defective Delivery May Fail to Administer Epinephrine.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41815-epipen-2-pak-auto-injectors-defective-delivery-may-fail-to. Based on FDA recall #D-0690-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0690-2017%22&limit=1).

The FDA announced on March 12, 2017, that Meridian Medical Technologies a Pfizer Company is voluntarily recalling EpiPen 2-Pak (Epinephrine) Auto-Injectors due to a defective delivery system. The hazard involves reports of the device failing to activate, which could prevent patients from receiving medication.

How to tell if you have it

  • Brand: Meridian Medical Technologies
  • Product: EpiPen 2-Pak (Epinephrine) Auto-Injectors 0.3 mg
  • NDC: 49502-500-02
  • U.S. Lots/Expiry: 5GM631 (April 2017), 5GM640 (May 2017), 6GM072 (Sep 2017), 6GM082 (Sep 2017), 6GM088 (Oct 2017), 6GM087 (Oct 2017), 6GM198 (Oct 2017), 6GM081 (Sep 2017), 6GM091 (Oct 2017), 6GM199 (Oct 2017)
  • International Lots/Expiry: 5FA665 (April 2017), 5GU763 (May 2017), 6FA293 (Oct 2017), 6FA292 (Oct 2017), 6GH294 (Oct 2017)
  • Quantity: 373,960 2-paks (U.S.); 331,738 auto-injectors (O.U.S.)
  • Distribution: Nationwide and Puerto Rico, Argentina, Austria, Australia, Belgium, Chile, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Latvia, Lithuania, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, Sweden, Switzerland, Taiwan, Thailand, United Kingdom

The hazard

The recall is due to a defective delivery system with reports of the device failing to activate. This malfunction could result in a patient not receiving the necessary medication.

Context

GovInfoNow's records show Meridian Medical Technologies a Pfizer Company has one other recall on record since June 6, 2012, involving Diazepam Injection due to impurities. FDA's FAERS database contains 63,401 adverse-event reports naming this product across all years, with 36,251 marked serious and 3,992 listing a death. Other recent recalls of similar products include Fresenius Kabi Epinephrine Injection Recall (May 14, 2026), EPINEPHR Sterility Risk in 1 mg/10mL Injection Recall (April 1, 2026), and American Regent Epinephrine Injection Recall (August 11, 2026).

How to tell if you have this one

Check for EpiPen 2-Pak auto-injectors labeled with the specific lots listed: US lots include 5GM631 (exp. April 2017) through 6GM199 (exp. Oct 2017), and international lots include 5FA665 (exp. April 2017) through 6GH294 (exp. Oct 2017).

  • Brand
    Meridian Medical Technologies
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class I
  • Status
    Ongoing
  • Distribution
    Nationwide and Puerto Rico, Argentina, Austria, Australia, Belgium, Chile, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Latvia, Lithuania, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, Sweden, Switzerland, Taiwan, Thailand, United Kingdom. There has been no U.S. government or military distribution.
  • NDC
    49502-500-01, 49502-500-02, 49502-500-92, 49502-501-01, 49502-501-02, 49502-501-92
Recall numberProduct, codes & lotsQuantity
D-0690-2017EpiPen 2-Pak (Epinephrine) Auto-Injectors 0.3 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- ALSO LABELED OUTSIDE THE US AS ---- Epipen Auto-Injector 0.3 mg -Bright Stock labeled for multiple countries- manufactured for Mylan by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company.; US: lot 5GM631, exp. April 2017; lot 5GM640, exp. May 2017; lot 6GM072, exp. Sep 2017; lot 6GM082, exp. Sep 2017; lot 6GM088, exp. Oct 2017; lot 6GM087, exp. Oct 2017; lot 6GM198, exp. Oct 2017; lot 6GM081, exp. Sep 2017; lot 6GM091, exp. Oct 2017; lot 6GM199, exp. Oct 2017: INTERNATIONAL: lot 5FA665, exp. April 2017; lot 5GU763, exp. May 2017; lot 6FA293, exp. Oct 2017; lot 6FA292, exp. Oct 2017; lot 6GH294, exp. Oct 2017.373,960 2-paks (U.S.) ; 331,738 auto-injectors (O.U.S.)
D-0691-2017EpiPen Jr. 2-Pak (Epinephrine) Auto-Injectors 0.15 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- ALSO LABELED OUTSIDE THE US AS: Epipen Auto-Injector Jr. 0.15 mg -Bright Stock labeled for multiple countries- manufactured for Mylan by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company.; US lot 5GN767, expiration April 2017; lot 5GN773, expiration April 2017; lot 6GN215, expiration Sep 2017: INTERNATIONAL lot 5GR765, expiration March 2017; lot 5GK771, expiration April 2017; lot 5ED824, expiration April 2017; and lot 6ED117, expiration ***92,544 2-pak (U.S.); 198,579 syringes (O.U.S.)
Based on the official FDA remedy

What to do — step by step

  1. Stop Using It Now

    Immediately stop using the recalled EpiPen 2-Pak auto-injectors as they may fail to activate during emergencies.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico, Argentina, Austria, Australia, Belgium, Chile, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Latvia, Lithuania, Netherlands, New Zealand, Norway, Poland, Portugal,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 59 days after the firm started it.

1. Firm started the recall: Mar 12, 201712. FDA classified it Class I: Apr 28, 201723. Published in FDA’s Enforcement Report: May 10, 201732017
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Fresenius Kabi Epinephrine Injection Recall: Failed Impurities May Cause Harm
Fresenius KabiEPINEPHR: Sterility Risk in 1 mg/10mL Injection Recall
International Medication SystemsApotex Recalls Paroxetine 37.5mg Due to Dissolution Failure
Apotex Corp.Ajanta Pharma Recalls Ranolazine 1000mg Due to Dissolution Failure
Ajanta Pharma USA IncClear Eyes Eye Drops Recall: Lack of Sterility Risk
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company

Latest drug recalls

Amneal Pharmaceuticals, LLC recalls Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater,
Amneal Pharmaceuticals · September 8, 2026Inventia Healthcare Limited recalls Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC:
Inventia Healthcare · September 3, 2026SV Labs Toronto Corporation recalls Benzoyl Peroxide Wash, USP, 10%, packaged in a)5 FL OZ (148mL) bottles (NDC 0536-1261-63), and b) 8.5 FL OZ (237 mL)
SV Labs · September 1, 2026SUN PHARMA /TARO recalls Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario,
SUN PHARMA /TARO · August 31, 2026Supernus Pharmaceuticals, Inc. recalls Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma
Supernus Pharmaceuticals · August 31, 2026Amneal Pharmaceuticals of New York, LLC recalls Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use
Amneal · August 28, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0690-2017 (March 12, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0690-2017 to see it in context.
  • Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA